Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
WOEST-3: DAPT vs Guideline-directed therapy in AF patients post-PCI
NCT04436978Phase 4Recruiting
- Start
- Jan 2023
- Primary completion
- Oct 2027
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 4 trial of edoxaban in Atrial fibrillation (AFib), atrial flutter (AFL). Started Jan 2023; status: recruiting.
02
Drugs
edoxaban
03
Conditions
Atrial fibrillation (AFib)atrial flutter (AFL)
Beyond the preview
Go deeper on NCT04436978.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04436978.